Exploratory PET/CT Radiomics for Predicting Early Progression in Locally Advanced Pancreatic Cancer
Authors:
- Michele FioreMFMichele Fiore
- Ermanno CordelliECErmanno Cordelli
- Gian Marco PetrianniGPGian Marco Petrianni
- Gabriele D’ErcoleGDGabriele D’Ercole
- Pasquale TreccaPTPasquale Trecca
- Silvia TaralliSTSilvia Taralli
- Vincenzo La VaccaraVVVincenzo La Vaccara
- Damiano CaputoDamiano Caputo
- Edy IppolitoEdy Ippolito
- Maria Lucia CalcagniMCMaria Lucia Calcagni
- Paolo SodaPSPaolo Soda
- Sara RamellaSRSara Ramella
Open Access
- 14 May 2026
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 16 (10) , 1499
Abstract
Background/Objectives: Early progression (EP) occurs in a subset of patients with locally advanced pancreatic cancer (LAPC), limiting the clinical benefit of treatment, and it remains difficult to predict. Methods: We developed a multiparametric predictive model integrating baseline 18F-FDG PET/CT radiomic features with clinical and biological data. A total of 242 radiomic features were extracted from each imaging modality (CT and PET), including first-order, gray-level co-occurrence matrix (GLCM), and local binary pattern (LBP-TOP) features, and combined with PET-derived metrics and clinical variables. Model development included cross-validation procedures and rigorous feature selection, followed by the training of a two-level decision tree classifier. Results: The model achieved an accuracy of 80.7% and an area under the curve (AUC) of 0.83. Integrated analysis of CT and PET texture enabled the identification of patients at high risk of EP prior to treatment initiation. Conclusions: PET/CT-based radiomic biomarkers, combined with clinical data, can non-invasively capture tumor heterogeneity and improve risk stratification in LAPC, supporting more personalized therapeutic decision-making.Keywords
This publication has 21 references indexed in Scilit:
- The value of PET/CT radiomics for predicting survival outcomes in patients with pancreatic ductal adenocarcinomaScientific Reports, 2024
- Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findingsEuropean Radiology, 2023
- Pancreas image mining: a systematic review of radiomicsEuropean Radiology, 2020
- CT and MRI of pancreatic tumors: an update in the era of radiomicsJapanese Journal of Radiology, 2020
- Prognostic value of FDG-PET radiomics with machine learning in pancreatic cancerScientific Reports, 2020
- Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2Critical Reviews in Oncology/Hematology, 2019
- miLBP: a robust and fast modality-independent 3D LBP for multimodal deformable registrationInternational Journal of Computer Assisted Radiology and Surgery, 2016
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachNature Communications, 2014
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapyCancer, 2007